
CELYAD ONCOLOGY Stock Over 21% Down In The Last 10 Sessions
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 21.69% in 10 sessions from €0.83 to €0.65 at 17:11 EST on Friday, after five consecutive sessions in a row of losses. BEL 20 is rising 0.06% to €3,826.46, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…